Maize 419 Promoter Tissue-Specific Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current plant genetic engineering techniques lack effective tools for site-specific regulation of gene expression, particularly in response to pathogens, which limits the targeted production of defensive compounds in transgenic plants.
Innovation Solution
Development of novel nucleotide sequences for tissue-specific promoters, such as the maize '419' promoter, which drives expression in specific plant tissues like stalks, roots, and silks, allowing for the controlled production of proteins in response to pathogens or environmental stresses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If constitutive promoters are used to achieve continuous expression throughout plant cells, then productivity is improved, but loss of substance increases due to expression in edible tissues
Solution Approach 1:
The patent applies tissue-specific promoters that confer different expression patterns to different plant tissues. For example, the promoter is active in non-edible tissues such as leaves, stems, and roots, but inactive in edible tissues such as seeds and fruits. This local differentiation allows the transgene to be expressed only where needed for defense, avoiding contamination of edible products while maintaining productivity.
Solution Approach 2:
The patent segments the plant genome by introducing multiple tissue-specific promoters, each controlling expression in specific tissue types. This segmentation allows independent control of gene expression across different tissues, enabling the plant to produce defensive compounds in non-edible tissues while keeping edible tissues free from foreign protein expression.
2Reliability
If inducible promoters are used to activate transcription in response to pathogens, then reliability is improved, but loss of time increases due to delayed response
Solution Approach 1:
The patent employs constitutive tissue-specific promoters that maintain low-level baseline expression even in the absence of pathogen stress. This preliminary expression ensures that defensive proteins are already present at low levels in non-edible tissues before pathogen attack, enabling immediate response without the delay associated with inducible promoters that require de novo transcriptional activation.
Solution Approach 2:
The patent modulates the expression level parameter by using tissue-specific promoters with different strength characteristics. The promoters are designed to provide constitutive low-level expression in non-edible tissues, creating a baseline that can be rapidly upregulated upon pathogen detection while avoiding the time lag of fully inducible systems.
3Loss of substance
If tissue-specific promoters are used to direct expression in non-edible tissues, then loss of substance is reduced, but device complexity increases
Solution Approach 1:
The patent utilizes naturally occurring tissue-specific promoters from the plant's own genome rather than introducing external regulatory elements. These endogenous promoters inherently possess the tissue-specificity required for selective expression in non-edible tissues, eliminating the need for complex synthetic promoter constructs and reducing overall device complexity while achieving the desired tissue-specific expression pattern.
Data Source
AI summary
The present disclosure provides compositions and methods for regulating expression of heterologous nucleotide sequences in a plant. Compositions include a novel nucleotide sequence for a tissue-preferred maize promoter. A method for expressing a heterologous nucleotide sequence in a plant using the promoter sequence disclosed herein is provided. The method comprises stably incorporating into the genome of a plant cell a nucleotide sequence operably linked to the root-preferred promoter of the present invention and regenerating a stably transformed plant that expresses the nucleotide sequence.


